New cancer clinical trial: Pre-operative Immunotherapy Combination Strategies in Breast Cancer

Published on: January 10, 2018 at 12:00PM
Conditions:   Breast Cancer;   Estrogen Receptor-positive Breast Cancer
Interventions:   Drug: Atezolizumab;   Drug: Cobimetinib;   Drug: Ipatasertib;   Drug: Bevacizumab
Sponsors:   Queen Mary University of London;   Kliniken Essen-Mitte;   MedSIR;   Asan Medical Center;   Hoffmann-La Roche
Recruiting
http://ift.tt/2qVoe54